**Core Concept**
Respiratory papillomatosis is a condition characterized by the growth of benign tumors in the air passages of the respiratory tract, often caused by the human papillomavirus (HPV). Topical treatments are used to manage this condition and prevent tumor recurrence.

**Why the Correct Answer is Right**
Cidofovir is an antiviral medication used for the treatment of respiratory papillomatosis. It works by inhibiting viral DNA replication, specifically targeting the HPV virus that causes the condition. Cidofovir is applied topically to the affected area, directly reducing the viral load and slowing tumor growth. This approach is particularly useful in managing recurrent respiratory papillomatosis.

**Why Each Wrong Option is Incorrect**
**Option A:** Acyclovir is an antiviral medication, but it is primarily used to treat herpes simplex virus (HSV) infections, not HPV. It is not the preferred treatment for respiratory papillomatosis.
**Option B:** Ranitidine is an H2 receptor antagonist used to reduce stomach acid production and is not related to the treatment of respiratory papillomatosis.
**Option D:** Ribavirin is an antiviral medication used to treat various viral infections, including respiratory syncytial virus (RSV) and hepatitis C. However, it is not the preferred treatment for respiratory papillomatosis.

**Clinical Pearl / High-Yield Fact**
Cidofovir is a valuable treatment option for patients with recurrent respiratory papillomatosis, offering a localized approach to reducing tumor growth and improving quality of life.

**✓ Correct Answer: C. Cidofovir**